LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, ...

The Moral Foundation of America

The idea that everyone has intrinsic rights to life and liberty was a radical break with millennia of human history. It’s ...

Teck Announces Completion of Comprehensive Operational Review and Updated Outlook

Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today provided an update on the progress of the Quebrada ...